Why is PharmaResources (Shanghai) Co., Ltd ?
1
With a growth in Net Sales of 28.81%, the company declared Outstanding results in Sep 25
- OPERATING CASH FLOW(Y) Highest at CNY 140.24 MM
- NET PROFIT(Q) At CNY 8.11 MM has Grown at 278.24%
- ROCE(HY) Highest at 3.53%
2
With ROE of 1.68%, it has a fair valuation with a 4.50 Price to Book Value
- Over the past year, while the stock has generated a return of 16.81%, its profits have risen by 48.6%
- At the current price, the company has a high dividend yield of 0.2
How much should you buy?
- Overall Portfolio exposure to PharmaResources (Shanghai) Co., Ltd should be less than 10%
- Overall Portfolio exposure to Miscellaneous should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Miscellaneous)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is PharmaResources (Shanghai) Co., Ltd for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
PharmaResources (Shanghai) Co., Ltd
16.81%
0.91
65.88%
China Shanghai Composite
16.01%
1.07
14.97%
Quality key factors
Factor
Value
Sales Growth (5y)
14.50%
EBIT Growth (5y)
-25.59%
EBIT to Interest (avg)
10.31
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.28
Sales to Capital Employed (avg)
0.49
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
348.46%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
5.27%
ROE (avg)
3.33%
Valuation Key Factors 
Factor
Value
P/E Ratio
269
Industry P/E
Price to Book Value
4.50
EV to EBIT
557.94
EV to EBITDA
45.66
EV to Capital Employed
5.84
EV to Sales
7.12
PEG Ratio
NA
Dividend Yield
0.22%
ROCE (Latest)
1.05%
ROE (Latest)
1.68%
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Mildly Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Dow Theory
Mildly Bearish
Bullish
OBV
Mildly Bearish
Bullish
Technical Movement
24What is working for the Company
OPERATING CASH FLOW(Y)
Highest at CNY 140.24 MM
NET PROFIT(Q)
At CNY 8.11 MM has Grown at 278.24%
ROCE(HY)
Highest at 3.53%
PRE-TAX PROFIT(Q)
At CNY 7.27 MM has Grown at 191.76%
RAW MATERIAL COST(Y)
Fallen by -81.28% (YoY
NET SALES(Q)
At CNY 161.24 MM has Grown at 28.81%
-6What is not working for the Company
DEBT-EQUITY RATIO
(HY)
Highest at -12.42 %
INTEREST COVERAGE RATIO(Q)
Lowest at 426.5
OPERATING PROFIT(Q)
Lowest at CNY 8.69 MM
OPERATING PROFIT MARGIN(Q)
Lowest at 5.39 %
Here's what is working for PharmaResources (Shanghai) Co., Ltd
Net Profit
At CNY 8.11 MM has Grown at 278.24%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very positive
Net Profit (CNY MM)
Operating Cash Flow
Highest at CNY 140.24 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (CNY MM)
Pre-Tax Profit
At CNY 7.27 MM has Grown at 191.76%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (CNY MM)
Net Sales
At CNY 161.24 MM has Grown at 28.81%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (CNY MM)
Raw Material Cost
Fallen by -81.28% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for PharmaResources (Shanghai) Co., Ltd
Interest Coverage Ratio
Lowest at 426.5
in the last five periodsMOJO Watch
The company's ability to manage interest payments is deteriorating
Operating Profit to Interest
Debt-Equity Ratio
Highest at -12.42 % and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Operating Profit
Lowest at CNY 8.69 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (CNY MM)
Operating Profit Margin
Lowest at 5.39 %
in the last five periodsMOJO Watch
Company's profit margin has deteriorated
Operating Profit to Sales






